News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
186 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17535)
Month
January (3398)
February (3796)
March (4054)
April (4079)
May (4309)
June (3941)
July (3248)
August (3087)
September (3751)
October (3897)
November (3988)
December (2885)
Day
2 (186)
3 (226)
4 (211)
5 (230)
6 (139)
9 (204)
10 (191)
11 (176)
12 (170)
13 (129)
16 (86)
17 (194)
18 (181)
19 (184)
20 (136)
22 (2)
23 (203)
24 (265)
25 (219)
26 (280)
27 (184)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
2
3
4
5
6
9
10
11
12
13
16
17
18
19
20
22
23
24
25
26
27
Policy
Repros Therapeutics Inc. Submits New Drug Application To FDA For Androxal®
February 2, 2015
·
3 min read
Drug Development
Aquinox Pharmaceuticals Completes Enrollment In The Phase 2 FLAGSHIP Trial Of AQX-1125 In Chronic Obstructive Pulmonary Disease Exacerbations
February 2, 2015
·
5 min read
FDA
IRIDEX Corporation Receives FDA Clearance for Cyclo G6™ Laser System for the Treatment of Multiple Stages of Glaucoma
February 2, 2015
·
3 min read
FDA
Zogenix, Inc. Receives FDA Approval Of New Formulation Of Zohydro® ER
February 2, 2015
·
8 min read
Business
IntelliPharmaCeutics Reports The Signing Of An Exclusive Licensing And Manufacturing Agreement With TEVA Pharmaceuticals USA For An Extended Release Oral Drug Product Candidate
February 2, 2015
·
6 min read
Drug Development
FDA Grants Breakthrough Therapy Designation For Genentech’s Investigational Cancer Immunotherapy MPDL3280A (Anti-PDL1) In Non-Small Cell Lung Cancer
February 2, 2015
·
3 min read
Drug Development
AbbVie Announces Top-Line Results From Phase 3 Study Of All-Oral Treatment For Hepatitis C In Japan
February 2, 2015
·
6 min read
Drug Development
Pluristem Therapeutics Announces Significant New Finding From Its Phase I/II Muscle Injury Trial And Excellent Safety Profile For PLX-PAD Cells At Twelve Months
February 2, 2015
·
5 min read
Drug Development
Protalix Biotherapeutics, Inc. Completes Enrollment In Phase I/II Clinical Trial Of PRX-102 For Fabry Disease
February 2, 2015
·
5 min read
Drug Development
Hemispherx Biopharma: US Army Scientists (USAMRIID) Find Ampligen(R) Produces 100% Survival Rate In Ebola Virus Rodent Study
February 2, 2015
·
10 min read
Previous
4 of 19
Next
